Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McGuirk

Showing results (481-490 of 583) with videos related to

Pageof 59
Sort By:
Blood|January 21, 2021
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trialEphraim J Fuchs, Paul V O'Donnell, Mary Eapen, et al.
Blood Advances|August 8, 2025
NKTR-255 Enhances Complete Response Following CD19 CAR-T in Patients with Relapsed/Refractory Large B-cell LymphomaSairah Ahmed, John F DiPersio, James H Essell, et al.
British Journal of Sports Medicine|September 29, 2018
International study of video review of concussion in professional sportsGavin A Davis, Michael Makdissi, Paul Bloomfield, et al.
BMC Health Services Research|April 4, 2024
A service mapping exercise of four health and social care staff mental health and wellbeing services, Resilience Hubs, to describe health service provision and interventionsKate Allsopp, Filippo Varese, Paul French, et al.
Blood|October 21, 2016
Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantationOmar S Aljitawi, Soumen Paul, Avishek Ganguly, et al.
Bone Marrow Transplantation|July 19, 2016
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantationJ Magenau, P Westervelt, S Khaled, et al.
Blood Advances|June 24, 2025
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCLRakesh Awasthi, Stephan A Grupp, Edward R Waldron, et al.
Transplantation and Cellular Therapy|June 13, 2024
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in MyelomaWilliam Wesson, Danai Dima, Nahid Suleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2021
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic SyndromeRyotaro Nakamura, Wael Saber, Michael J Martens, et al.
Seminars in Pediatric Surgery|June 11, 2026
Radio-surgical decision-making in hepatoblastoma in the post-PHITT era: SIOPEL consensus recommendationsJuri Fuchs, Siri M H Lohne, Víola Weeda, et al.
Pageof 59

Showing results (481-490 of 583) with videos related to

Sort By:
Pageof 59
Blood|January 21, 2021
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trialEphraim J Fuchs, Paul V O'Donnell, Mary Eapen, et al.
Blood Advances|August 8, 2025
NKTR-255 Enhances Complete Response Following CD19 CAR-T in Patients with Relapsed/Refractory Large B-cell LymphomaSairah Ahmed, John F DiPersio, James H Essell, et al.
British Journal of Sports Medicine|September 29, 2018
International study of video review of concussion in professional sportsGavin A Davis, Michael Makdissi, Paul Bloomfield, et al.
BMC Health Services Research|April 4, 2024
A service mapping exercise of four health and social care staff mental health and wellbeing services, Resilience Hubs, to describe health service provision and interventionsKate Allsopp, Filippo Varese, Paul French, et al.
Blood|October 21, 2016
Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantationOmar S Aljitawi, Soumen Paul, Avishek Ganguly, et al.
Bone Marrow Transplantation|July 19, 2016
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantationJ Magenau, P Westervelt, S Khaled, et al.
Blood Advances|June 24, 2025
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCLRakesh Awasthi, Stephan A Grupp, Edward R Waldron, et al.
Transplantation and Cellular Therapy|June 13, 2024
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in MyelomaWilliam Wesson, Danai Dima, Nahid Suleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2021
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic SyndromeRyotaro Nakamura, Wael Saber, Michael J Martens, et al.
Seminars in Pediatric Surgery|June 11, 2026
Radio-surgical decision-making in hepatoblastoma in the post-PHITT era: SIOPEL consensus recommendationsJuri Fuchs, Siri M H Lohne, Víola Weeda, et al.
Pageof 59